Come up with a name for your new list and we'll add to it:
Vista Therapeutics raised a round of funding on February 05, 2009. Investors include
TEL Venture Capital.
Vista Therapeutics, Inc. is commercializing nanowire-based biosensors that will allow for real-time, continuous, label-free monitoring of multiple biomarkers, simultaneously at femtomolar concentratio…